Felix Gerhard Maria Dietlein, M.D., Ph.D.
This page shows the publications Felix Dietlein has written about Signal Transduction.
Molecular pathways: exploiting tumor-specific molecular defects in DNA repair pathways for precision cancer therapy. Clin Cancer Res. 2014 Dec 01; 20(23):5882-7.
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches. Trends Genet. 2014 Aug; 30(8):326-39.
A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proc Natl Acad Sci U S A. 2012 Oct 16; 109(42):17034-9.
Integrated molecular drivers coordinate biological and clinical states in melanoma. Nat Genet. 2020 12; 52(12):1373-1383.
The tumour suppressor CYLD regulates the p53 DNA damage response. Nat Commun. 2016 08 26; 7:12508.
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer. Cancer Discov. 2014 Feb; 4(2):246-57.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.